The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

Tirzepatide, semaglutide, and liraglutide lead to weight loss in adults with obesity and T1D over 1 year; the greatest weight loss and a modest decrease in A1c levels are seen with tirzepatide.

Amid soaring global demand for glucagon-like peptide-1 (GLP-1) medications and widespread concerns about affordability and access, the World Health Organization (WHO) released its global comprehensive ...

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which ...

Please provide your email address to receive an email when new articles are posted on . The American Diabetes Association Scientific Sessions featured symposia on novel treatments for diabetes and ...

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

Diabetes, obesity, and cardiovascular issues are interconnected, impacting millions in India. Meril and The Times of India's ...

A study conducted at Harvard University identified a group of metabolites that travel from the intestine to the liver and ...

The National Longitudinal Study of Adolescent Health enrolled a cohort of adolescents 11-21 years of age who were representative of the US school population in grades 7-12 in 1994-1995 (wave 1). The ...

Rising global lifestyle-related illnesses are reshaping the claims landscape and creating long-term cost pressures for international medical insurers ...

Do diabetes and obesity raise pancreatic cancer risk? An oncologist shares 8 silent symptoms and prevention tips backed by ...

Pakistan's diabetes crisis is now among the worst in the world, but health experts warn that only half the battle is being fought. Obesity, a critical driver of Type 2 diabetes, remains largely ...